ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1364

Development, Sensibility and Reliability of a New Case-Finding Questionnaire, the Toronto Axial Spondyloarthritis Questionnaire in Inflammatory Bowel Disease

Khalid A. Alnaqbi1, Zahi Touma1, Laura A. Passalent2, Sindhu R. Johnson1, George A. Tomlinson3, Adele Carty1 and Robert D. Inman1, 1Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, 2Allied Health, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 3Dept of Medicine/Rheumatology, Toronto General Hospital, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Questionnaires and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: Inflammatory bowel disease (IBD) encompasses Crohn’s disease, ulcerative colitis, and indeterminate colitis. Articular involvement [(peripheral arthritis and axial spondyloarthritis (axSpA)] is the most common extra-intestinal manifestation. There is an unacceptable delay in diagnosis of axSpA by 8-11 years. Our aim was to develop a sensible and reliable questionnaire that identifies undetected axSpA among IBD patients and facilitates timely referral to rheumatologists.

Methods: Literature review facilitated identification of 3 domains:1) IBD, 2) inflammatory back symptoms, and 3) extra-axial features. Items of the Toronto Axial Spondyloarthritis Questionnaire (TASQ) were evaluated for sensibility among SpA team, 2 general rheumatologists, and axSpA patients. Sensibility assessment was related to purpose and framework (clinical function, clinical justification, clinical applicability), face validity, comprehensibility (oligovariability, transparency), replicability, content validity, and feasibility. For the test-retest reliability study, the final version of TASQ was mailed to 77 patients with established IBD and axSpA, who were followed at the Spondylitis clinic. Patients were instructed to complete the questionnaire on 2 occasions 1-2 weeks apart. Calculated sample size was 23 for reliability. Kappa statistics were calculated for the binary response options of each item.

Results : Item modification and reduction led to drafting version 4 of TASQ consisting of 16 items on a one-page double-sided document with a diagram of the back. Of the 77 patients, 34 responded to the TASQ. Responders and non-responders did not differ in terms of age, sex, level of education, types of IBD, BASDAI, BASFI, ESR and CRP levels. Kappa agreement coefficient ranged from 0.81 to 1.00 indicating almost perfect agreement. Absolute agreement of all items ranged from 91 to 100%.

Table 1

Table 2

Conclusion : TASQ is a newly developed, sensible and reliable questionnaire to be administered to patients with IBD who have ever had chronic back pain or stiffness that lasted ³ 3 months. TASQ should facilitate identification and referral of IBD patients to rheumatologists and should avoid delay in diagnosis of axSpA.


Disclosure:

K. A. Alnaqbi,
None;

Z. Touma,
None;

L. A. Passalent,
None;

S. R. Johnson,
None;

G. A. Tomlinson,
None;

A. Carty,
None;

R. D. Inman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-sensibility-and-reliability-of-a-new-case-finding-questionnaire-the-toronto-axial-spondyloarthritis-questionnaire-in-inflammatory-bowel-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology